Tweets
QD Clinic - daily lessons and cases from the Rheumatology clinic.
RA patient, not quite controlled, needs to optimized MTX therapy
Features Dr. Jack Cush https://t.co/ZoX2biwv7M
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
FDA sent an "untitled"letter to "R3 Stem Cell" for touting birth tissue products as Rx for ailments (without scientific evidence). FDA also won a case against "US Stem Cell clinics" for adulterated & misbranded stem cell products https://t.co/bQpRHxR9G8 https://t.co/oLBPKZ1lxX
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Word of the day:
Ischuria= urinary retention.
My patient with systemic sclerosis and severe spinal stenosis developed ischuria and now has to self-cath.
#rheumnow
k dao @KDAO2011 ( View Tweet )
7 years 2 months ago
Transparency is coming? The Prices will soon be Included in TV Drug Ads. HHS Secretary Alex Azar has finalized regulations requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. https://t.co/P2DPwXGYXK
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
The overall prevalence of gout among US adults is 3.9%, affecting 9.2 million people. Hyperuricaemia prevalence is 14.6% - affecting 32.5 million in the US. Data from NHANES NHANES 2015–16 https://t.co/3g05GmUDUA
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Korean Natl Claims Database examined RA & risk of opportunistic infx- OI, H zoster & candidiasis are seen in early RA. SIR for OI in early RA=1.14 (95% CI, 1.05‐1.23). H zoster (1.12), candidiasis (2.40); Age, steroids & comorbidity increased OI risk https://t.co/U7LPMpmPqG
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
CDC has updated its recommendations for TB testing of health care personnel. All HCP should be tested initially but after TB risk assessment, there is no need for routine or serial TB testing in the absence of exposure or ongoing risk of TB. https://t.co/qtAdz8d7OK
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Metformin, was given to a mouse model Sjogrens (NOD)/ShiLtJ mice) & reduced salivary inflammation, IL-6,TNFα, IL-17 mRNA, improved salivary flow rate, suppressed effector T cells, inducec regulatory T cells & B cell diff. Why are mice so easy, SS so tough? https://t.co/yC5fJIBBEx
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Here's the application for A&R Editor position 2020-2025 https://t.co/IoyxAECAJ0
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
he American College of Rheumatology invites applications for the position of Editor, Arthritis & Rheumatology for the 2020 - 2025 term. The deadline to submit an application is June 21, 2019.
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
UK Clinical Practice Database matched 62,234 pts with and without gout showing more venous thromboembolic events in gout (0.373 vs 0.27 per 100 Pt-yrs) (aHR 1.25, 95% CI 1.15–1.35) - not affected by ULT & not significant while in hospital (aHR 1.01) https://t.co/XrInEwckez
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
RheumNow is featuring "Therapeutic Update: Biosimilars in Rheumatology" with video insights from several experts, including Drs. Alvin Wells, Eric Ruderman, Vibeke Strand, Lee Simon and others. Sponsored by Sandoz, Inc.; available on RheumNow https://t.co/1vmnEJqOSi #sponsored
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
RheumNow Podcast is up! What to monitor with RTX therapy. Watch here> https://t.co/1aTy1axjXL or listen to the podcast on iTunes or SoundCloud>> https://t.co/fBY6O052NR
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Prospective study of 4796 pts in the Osteoarthritis Initiative shows metformin use in obese pts (BMI>30) was Assoc with significantly less medial cartilage loss (0.71% vs. 1.57%/yr) & a trend towards fewer knee replacements over 6 yrs (OR 0.30, p = 0.11) https://t.co/LD0jFWtSLM
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
Japanese study 198 systemic sclerosis pts finds higher skin thickness scores (modified Rodnan Skin Scores; mRSS) associated with higher risk of interstitial lung disease (P < 0.05), restrictive LDz(P < 0.01), and diffusion impairment (P < 0.05) https://t.co/PY4n6N5Ub9
Links:
Dr. John Cush @RheumNow ( View Tweet )
7 years 2 months ago
